Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hemostasis disorders in chronic renal failure

¹Department of Medicine I, Charles University School of Medicine, Plzen, Czech Republic.

Kidney International. Supplement

|November 14, 1997

Summary

Chronic renal failure (CRF) patients exhibit impaired fibrinolysis, worsening with declining kidney function. This hypofibrinolysis may contribute to thrombosis and atherosclerosis in dialysis patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Influence of continuous ambulatory peritoneal dialysis on some plasma and erythrocyte vitamins--retrospective study.

Prague medical report·2009

Same author

[Free radicals and extracorporeal renal replacement therapy].

Vnitrni lekarstvi·2005

Same author

[The role of cytokines in peritoneal dialysis].

Vnitrni lekarstvi·2005

Same author

[Results of proteomic-based study of the kidney, urine, plasma, and uremic ultrafiltrate. Potential applications of the results in nephrology].

Vnitrni lekarstvi·2004

Same author

[The first conferences of dialysis nurses and staff in Czechoslovakia].

Vnitrni lekarstvi·2004

Same author

[Pure red cell aplasia in erythropoietin therapy in patients with kidney failure].

Casopis lekaru ceskych·2004

Area of Science:

Nephrology
Hematology
Cardiovascular Medicine

Background:

Patients undergoing dialysis for chronic renal failure (CRF) often present with impaired fibrinolysis.
This defect in fibrinolysis is linked to plasminogen activation and worsens as renal function deteriorates.
Reduced fibrinolysis is a potential contributing factor to thrombosis, atherosclerosis, and associated complications in CRF.

Purpose of the Study:

To investigate the relationship between fibrinolysis defects in CRF and prothrombotic metabolic disorders.
To determine if hypofibrinolysis improves with the treatment of these metabolic disorders.
To explore a potential causative link between decreased fibrinolysis and thrombotic complications in CRF patients.

Main Methods:

The abstract does not specify the methods used in the study.
Further details on patient cohorts, diagnostic techniques for fibrinolysis, and metabolic disorder assessments are needed.
The study likely involved analyzing blood samples and clinical data from dialysis patients with CRF.

Main Results:

The abstract indicates a clear defect in fibrinolysis at the plasminogen activation level in dialysis patients with CRF.
The severity of the fibrinolysis defect correlates with the decline in renal function.
The abstract highlights unanswered questions regarding the interplay between hypofibrinolysis, metabolic disorders, and thrombotic events.

Conclusions:

Dialysis patients with CRF have a significant fibrinolysis defect that progresses with worsening renal function.
This hypofibrinolysis is implicated in the pathogenesis of thrombosis and atherosclerosis in this population.
Further research is needed to elucidate the complex relationships between CRF, metabolic disturbances, fibrinolysis, and thrombotic risk.

Related Experiment Videos